| Model Number |
DTMA1D1 |
| Medical Device Problem Codes |
Defibrillation/Stimulation Problem (1573); Device Sensing Problem (2917)
|
| Health Effect - Clinical Codes |
Chest Pain (1776); Ventricular Fibrillation (2130)
|
| Date of Event |
01/07/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that therapy was initially inappropriately withheld for ventricular fibrillation (vf) that the cardiac resynchronization therapy defibrillator (crt-d) detected as supra ventricular tachycardia (svt) due to wavelet.In addition, the right ventricular (rv) lead exhibited oversensing resulting in t-wave oversensing (twos).It was also noted that the patient experienced chest pain.The crt-d and rv lead remain in use.No further patient complications have been reported as a result of this event.
|
| |
|
Search Alerts/Recalls
|